aluates Reports

$ 0.0

Automative

Global Androgen Suppression Therapy Market Insights, Forecast to 2030

Published Date: November 2024

Report Code: QYRE-Auto-17T13038

Global Androgen Suppression Therapy Market Research Report 2023

BUY CHAPTERS

Global Androgen Suppression Therapy Market Insights, Forecast to 2030

Code: QYRE-Auto-17T13038

Report

November 2024

Pages:114

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Pfizer Inc

Astellas

Johnson & Johnson

Astrazeneca plc

Bayer

Merck

Tolmar

Ferring Pharmaceuticals

Jiangsu Hengrui Pharmaceuticals

CTTQ

Zoladex

Androgen Suppression Therapy Market Size

The global Androgen Suppression Therapy market is projected to grow from US$ 11300 million in 2024 to US$ 15320 million by 2030, at a Compound Annual Growth Rate (CAGR) of 5.2% during the forecast period.

Androgen Suppression Therapy Market

Androgen suppression therapy (ADT), also known as hormone therapy, is a medical treatment that lowers the levels of male hormones, called androgens (primarily testosterone). It's primarily used for treating prostate cancer and sometimes other conditions that are affected by androgens.

Market Analysis and Insights: Global Androgen Suppression Therapy Market

The Androgen Suppression Therapy (ADT) market is expected to see steady growth in the coming years, driven by several key factors:

Market Drivers:

Rising incidence of prostate cancer: Prostate cancer is the most common cancer among men worldwide, and Androgen Suppression Therapy remains a cornerstone treatment option, fueling market demand.

Aging population: With an increasing aging population, the prevalence of prostate cancer and other conditions treated with Androgen Suppression Therapy is expected to rise, further propelling market growth.

Evolving treatment protocols: Advancements in medical research are leading to new and personalized approaches to Androgen Suppression Therapy, including shorter treatment durations and combination therapies, expanding market options.

Increasing awareness and access to treatment: Growing awareness about prostate cancer and its treatment options, coupled with improved healthcare access in some regions, is driving higher uptake of Androgen Suppression Therapy.

Development of novel formulations and delivery systems: Advancements in drug delivery, like long-acting injectable medications and oral medications with fewer side effects, are improving patient compliance and potentially expanding the market reach.

Challenges and Future Outlook:

Cost-effectiveness concerns: Androgen Suppression Therapy can be expensive, and rising healthcare costs could limit accessibility for patients in some regions.

Side effects and long-term health impacts: The potential side effects of Androgen Suppression Therapy, including bone loss and cardiovascular risks, require ongoing research and development of safer and more effective treatment options.

Patient compliance: Addressing concerns about side effects and ensuring adherence to treatment protocols remain crucial for achieving optimal treatment outcomes.

Despite these challenges, the Androgen Suppression Therapy market holds promising potential for sustained growth. Continued research into novel therapies, improved access to treatment, and developing personalized treatment plans will be key factors in shaping the future of this market.

Report Covers:

This report presents an overview of global market for Androgen Suppression Therapy market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Androgen Suppression Therapy, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Androgen Suppression Therapy, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Androgen Suppression Therapy revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Androgen Suppression Therapy market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Androgen Suppression Therapy revenue, projected growth trends, production technology, application and end-user industry.

Market Segmentation

Scope of Androgen Suppression Therapy Market Report

Report Metric	Details
Report Name	Androgen Suppression Therapy Market
Accounted market size in 2024	US$ 11300 in million
Forecasted market size in 2030	US$ 15320 million
CAGR	5.2
Base Year	2024
Forecasted years	2024 - 2030
Segment by Type	Tablet Injection
Segment by Application	Hospital Clinic Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Pfizer, Astellas, Johnson & Johnson, AstraZeneca, Bayer, Merck, Tolmar, Zoladex, Ferring Pharmaceuticals, Jiangsu Hengrui Pharmaceuticals, CTTQ
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Androgen Suppression Therapy in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Androgen Suppression Therapy companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Androgen Suppression Therapy revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

How fast is Androgen Suppression Therapy Market growing?

Ans: The Androgen Suppression Therapy Market witnessing a CAGR of 5.2 during the forecast period 2024-2030.

What is the Androgen Suppression Therapy Market size in 2030?

Ans: The Androgen Suppression Therapy Market size in 2030 will be US$ 15320 million.

Who are the main players in the Androgen Suppression Therapy Market report?

Ans: The main players in the Androgen Suppression Therapy Market are Pfizer, Astellas, Johnson & Johnson, AstraZeneca, Bayer, Merck, Tolmar, Zoladex, Ferring Pharmaceuticals, Jiangsu Hengrui Pharmaceuticals, CTTQ

What are the Application segmentation covered in the Androgen Suppression Therapy Market report?

Ans: The Applications covered in the Androgen Suppression Therapy Market report are Hospital, Clinic, Others

What are the Type segmentation covered in the Androgen Suppression Therapy Market report?

Ans: The Types covered in the Androgen Suppression Therapy Market report are Tablet, Injection

Recommended Reports

Prostate Cancer Treatment

Hormone & Androgen Therapy

Male Health Disorders

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Androgen Suppression Therapy Market Size Growth Rate by Type, 2019 VS 2023 VS 2030

1.2.2 Tablet

1.2.3 Injection

1.3 Market by Application

1.3.1 Global Androgen Suppression Therapy Market Size Growth Rate by Application, 2019 VS 2023 VS 2030

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Androgen Suppression Therapy Market Perspective (2019-2030)

2.2 Global Androgen Suppression Therapy Growth Trends by Region

2.2.1 Androgen Suppression Therapy Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Androgen Suppression Therapy Historic Market Size by Region (2019-2024)

2.2.3 Androgen Suppression Therapy Forecasted Market Size by Region (2025-2030)

2.3 Androgen Suppression Therapy Market Dynamics

2.3.1 Androgen Suppression Therapy Industry Trends

2.3.2 Androgen Suppression Therapy Market Drivers

2.3.3 Androgen Suppression Therapy Market Challenges

2.3.4 Androgen Suppression Therapy Market Restraints

3 Competition Landscape by Key Players

3.1 Global Revenue Androgen Suppression Therapy by Players

3.1.1 Global Androgen Suppression Therapy Revenue by Players (2019-2024)

3.1.2 Global Androgen Suppression Therapy Revenue Market Share by Players (2019-2024)

3.2 Global Androgen Suppression Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players of Androgen Suppression Therapy, Ranking by Revenue, 2022 VS 2023 VS 2024

3.4 Global Androgen Suppression Therapy Market Concentration Ratio

3.4.1 Global Androgen Suppression Therapy Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Androgen Suppression Therapy Revenue in 2023

3.5 Global Key Players of Androgen Suppression Therapy Head office and Area Served

3.6 Global Key Players of Androgen Suppression Therapy, Product and Application

3.7 Global Key Players of Androgen Suppression Therapy, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Androgen Suppression Therapy Breakdown Data by Type

4.1 Global Androgen Suppression Therapy Historic Market Size by Type (2019-2024)

4.2 Global Androgen Suppression Therapy Forecasted Market Size by Type (2025-2030)

5 Androgen Suppression Therapy Breakdown Data by Application

5.1 Global Androgen Suppression Therapy Historic Market Size by Application (2019-2024)

5.2 Global Androgen Suppression Therapy Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Androgen Suppression Therapy Market Size (2019-2030)

6.2 North America Androgen Suppression Therapy Market Size by Type

6.2.1 North America Androgen Suppression Therapy Market Size by Type (2019-2024)

6.2.2 North America Androgen Suppression Therapy Market Size by Type (2025-2030)

6.2.3 North America Androgen Suppression Therapy Market Share by Type (2019-2030)

6.3 North America Androgen Suppression Therapy Market Size by Application

6.3.1 North America Androgen Suppression Therapy Market Size by Application (2019-2024)

6.3.2 North America Androgen Suppression Therapy Market Size by Application (2025-2030)

6.3.3 North America Androgen Suppression Therapy Market Share by Application (2019-2030)

6.4 North America Androgen Suppression Therapy Market Size by Country

6.4.1 North America Androgen Suppression Therapy Market Size by Country: 2019 VS 2023 VS 2030

6.4.2 North America Androgen Suppression Therapy Market Size by Country (2019-2024)

6.4.3 North America Androgen Suppression Therapy Market Size by Country (2025-2030)

6.4.4 United States

6.4.5 Canada

7 Europe

7.1 Europe Androgen Suppression Therapy Market Size (2019-2030)

7.2 Europe Androgen Suppression Therapy Market Size by Type

7.2.1 Europe Androgen Suppression Therapy Market Size by Type (2019-2024)

7.2.2 Europe Androgen Suppression Therapy Market Size by Type (2025-2030)

7.2.3 Europe Androgen Suppression Therapy Market Share by Type (2019-2030)

7.3 Europe Androgen Suppression Therapy Market Size by Application

7.3.1 Europe Androgen Suppression Therapy Market Size by Application (2019-2024)

7.3.2 Europe Androgen Suppression Therapy Market Size by Application (2025-2030)

7.3.3 Europe Androgen Suppression Therapy Market Share by Application (2019-2030)

7.4 Europe Androgen Suppression Therapy Market Size by Country

7.4.1 Europe Androgen Suppression Therapy Market Size by Country: 2019 VS 2023 VS 2030

7.4.2 Europe Androgen Suppression Therapy Market Size by Country (2019-2024)

7.4.3 Europe Androgen Suppression Therapy Market Size by Country (2025-2030)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 China

8.1 China Androgen Suppression Therapy Market Size (2019-2030)

8.2 China Androgen Suppression Therapy Market Size by Type

8.2.1 China Androgen Suppression Therapy Market Size by Type (2019-2024)

8.2.2 China Androgen Suppression Therapy Market Size by Type (2025-2030)

8.2.3 China Androgen Suppression Therapy Market Share by Type (2019-2030)

8.3 China Androgen Suppression Therapy Market Size by Application

8.3.1 China Androgen Suppression Therapy Market Size by Application (2019-2024)

8.3.2 China Androgen Suppression Therapy Market Size by Application (2025-2030)

8.3.3 China Androgen Suppression Therapy Market Share by Application (2019-2030)

9 Asia (excluding China)

9.1 Asia Androgen Suppression Therapy Market Size (2019-2030)

9.2 Asia Androgen Suppression Therapy Market Size by Type

9.2.1 Asia Androgen Suppression Therapy Market Size by Type (2019-2024)

9.2.2 Asia Androgen Suppression Therapy Market Size by Type (2025-2030)

9.2.3 Asia Androgen Suppression Therapy Market Share by Type (2019-2030)

9.3 Asia Androgen Suppression Therapy Market Size by Application

9.3.1 Asia Androgen Suppression Therapy Market Size by Application (2019-2024)

9.3.2 Asia Androgen Suppression Therapy Market Size by Application (2025-2030)

9.3.3 Asia Androgen Suppression Therapy Market Share by Application (2019-2030)

9.4 Asia Androgen Suppression Therapy Market Size by Region

9.4.1 Asia Androgen Suppression Therapy Market Size by Region: 2019 VS 2023 VS 2030

9.4.2 Asia Androgen Suppression Therapy Market Size by Region (2019-2024)

9.4.3 Asia Androgen Suppression Therapy Market Size by Region (2025-2030)

9.4.4 Japan

9.4.5 South Korea

9.4.6 China Taiwan

9.4.7 Southeast Asia

9.4.8 India

9.4.9 Australia

10 Middle East, Africa, and Latin America

10.1 Middle East, Africa, and Latin America Androgen Suppression Therapy Market Size (2019-2030)

10.2 Middle East, Africa, and Latin America Androgen Suppression Therapy Market Size by Type

10.2.1 Middle East, Africa, and Latin America Androgen Suppression Therapy Market Size by Type (2019-2024)

10.2.2 Middle East, Africa, and Latin America Androgen Suppression Therapy Market Size by Type (2025-2030)

10.2.3 Middle East, Africa, and Latin America Androgen Suppression Therapy Market Share by Type (2019-2030)

10.3 Middle East, Africa, and Latin America Androgen Suppression Therapy Market Size by Application

10.3.1 Middle East, Africa, and Latin America Androgen Suppression Therapy Market Size by Application (2019-2024)

10.3.2 Middle East, Africa, and Latin America Androgen Suppression Therapy Market Size by Application (2025-2030)

10.3.3 Middle East, Africa, and Latin America Androgen Suppression Therapy Market Share by Application (2019-2030)

10.4 Middle East, Africa, and Latin America Androgen Suppression Therapy Market Size by Country

10.4.1 Middle East, Africa, and Latin America Androgen Suppression Therapy Market Size by Country: 2019 VS 2023 VS 2030

10.4.2 Middle East, Africa, and Latin America Androgen Suppression Therapy Market Size by Country (2019-2024)

10.4.3 Middle East, Africa, and Latin America Androgen Suppression Therapy Market Size by Country (2025-2030)

10.4.4 Brazil

10.4.5 Mexico

10.4.6 Turkey

10.4.7 Saudi Arabia

10.4.8 Israel

10.4.9 GCC Countries

11 Key Players Profiles

11.1 Pfizer

11.1.1 Pfizer Company Details

11.1.2 Pfizer Business Overview

11.1.3 Pfizer Androgen Suppression Therapy Introduction

11.1.4 Pfizer Revenue in Androgen Suppression Therapy Business (2019-2024)

11.1.5 Pfizer Recent Developments

11.2 Astellas

11.2.1 Astellas Company Details

11.2.2 Astellas Business Overview

11.2.3 Astellas Androgen Suppression Therapy Introduction

11.2.4 Astellas Revenue in Androgen Suppression Therapy Business (2019-2024)

11.2.5 Astellas Recent Developments

11.3 Johnson & Johnson

11.3.1 Johnson & Johnson Company Details

11.3.2 Johnson & Johnson Business Overview

11.3.3 Johnson & Johnson Androgen Suppression Therapy Introduction

11.3.4 Johnson & Johnson Revenue in Androgen Suppression Therapy Business (2019-2024)

11.3.5 Johnson & Johnson Recent Developments

11.4 AstraZeneca

11.4.1 AstraZeneca Company Details

11.4.2 AstraZeneca Business Overview

11.4.3 AstraZeneca Androgen Suppression Therapy Introduction

11.4.4 AstraZeneca Revenue in Androgen Suppression Therapy Business (2019-2024)

11.4.5 AstraZeneca Recent Developments

11.5 Bayer

11.5.1 Bayer Company Details

11.5.2 Bayer Business Overview

11.5.3 Bayer Androgen Suppression Therapy Introduction

11.5.4 Bayer Revenue in Androgen Suppression Therapy Business (2019-2024)

11.5.5 Bayer Recent Developments

11.6 Merck

11.6.1 Merck Company Details

11.6.2 Merck Business Overview

11.6.3 Merck Androgen Suppression Therapy Introduction

11.6.4 Merck Revenue in Androgen Suppression Therapy Business (2019-2024)

11.6.5 Merck Recent Developments

11.7 Tolmar

11.7.1 Tolmar Company Details

11.7.2 Tolmar Business Overview

11.7.3 Tolmar Androgen Suppression Therapy Introduction

11.7.4 Tolmar Revenue in Androgen Suppression Therapy Business (2019-2024)

11.7.5 Tolmar Recent Developments

11.8 Zoladex

11.8.1 Zoladex Company Details

11.8.2 Zoladex Business Overview

11.8.3 Zoladex Androgen Suppression Therapy Introduction

11.8.4 Zoladex Revenue in Androgen Suppression Therapy Business (2019-2024)

11.8.5 Zoladex Recent Developments

11.9 Ferring Pharmaceuticals

11.9.1 Ferring Pharmaceuticals Company Details

11.9.2 Ferring Pharmaceuticals Business Overview

11.9.3 Ferring Pharmaceuticals Androgen Suppression Therapy Introduction

11.9.4 Ferring Pharmaceuticals Revenue in Androgen Suppression Therapy Business (2019-2024)

11.9.5 Ferring Pharmaceuticals Recent Developments

11.10 Jiangsu Hengrui Pharmaceuticals

11.10.1 Jiangsu Hengrui Pharmaceuticals Company Details

11.10.2 Jiangsu Hengrui Pharmaceuticals Business Overview

11.10.3 Jiangsu Hengrui Pharmaceuticals Androgen Suppression Therapy Introduction

11.10.4 Jiangsu Hengrui Pharmaceuticals Revenue in Androgen Suppression Therapy Business (2019-2024)

11.10.5 Jiangsu Hengrui Pharmaceuticals Recent Developments

11.11 CTTQ

11.11.1 CTTQ Company Details

11.11.2 CTTQ Business Overview

11.11.3 CTTQ Androgen Suppression Therapy Introduction

11.11.4 CTTQ Revenue in Androgen Suppression Therapy Business (2019-2024)

11.11.5 CTTQ Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Pfizer Inc

Astellas

Johnson & Johnson

Astrazeneca plc

Bayer

Merck

Tolmar

Ferring Pharmaceuticals

Jiangsu Hengrui Pharmaceuticals

CTTQ

Zoladex

List of Tables

Table 1. Global Androgen Suppression Therapy Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030

Table 2. Key Players of Tablet

Table 3. Key Players of Injection

Table 4. Global Androgen Suppression Therapy Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030

Table 5. Global Androgen Suppression Therapy Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global Androgen Suppression Therapy Market Size by Region (2019-2024) & (US$ Million)

Table 7. Global Androgen Suppression Therapy Market Share by Region (2019-2024)

Table 8. Global Androgen Suppression Therapy Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 9. Global Androgen Suppression Therapy Market Share by Region (2025-2030)

Table 10. Androgen Suppression Therapy Market Trends

Table 11. Androgen Suppression Therapy Market Drivers

Table 12. Androgen Suppression Therapy Market Challenges

Table 13. Androgen Suppression Therapy Market Restraints

Table 14. Global Androgen Suppression Therapy Revenue by Players (2019-2024) & (US$ Million)

Table 15. Global Androgen Suppression Therapy Revenue Share by Players (2019-2024)

Table 16. Global Top Androgen Suppression Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Androgen Suppression Therapy as of 2023)

Table 17. Global Androgen Suppression Therapy Industry Ranking 2022 VS 2023 VS 2024

Table 18. Global 5 Largest Players Market Share by Androgen Suppression Therapy Revenue (CR5 and HHI) & (2019-2024)

Table 19. Global Key Players of Androgen Suppression Therapy, Headquarters and Area Served

Table 20. Global Key Players of Androgen Suppression Therapy, Product and Application

Table 21. Global Key Players of Androgen Suppression Therapy, Product and Application

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Androgen Suppression Therapy Market Size by Type (2019-2024) & (US$ Million)

Table 24. Global Androgen Suppression Therapy Revenue Market Share by Type (2019-2024)

Table 25. Global Androgen Suppression Therapy Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 26. Global Androgen Suppression Therapy Revenue Market Share by Type (2025-2030)

Table 27. Global Androgen Suppression Therapy Market Size by Application (2019-2024) & (US$ Million)

Table 28. Global Androgen Suppression Therapy Revenue Share by Application (2019-2024)

Table 29. Global Androgen Suppression Therapy Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 30. Global Androgen Suppression Therapy Revenue Share by Application (2025-2030)

Table 31. North America Androgen Suppression Therapy Market Size by Type (2019-2024) & (US$ Million)

Table 32. North America Androgen Suppression Therapy Market Size by Type (2025-2030) & (US$ Million)

Table 33. North America Androgen Suppression Therapy Market Size by Application (2019-2024) & (US$ Million)

Table 34. North America Androgen Suppression Therapy Market Size by Application (2025-2030) & (US$ Million)

Table 35. North America Androgen Suppression Therapy Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 36. North America Androgen Suppression Therapy Market Size by Country (2019-2024) & (US$ Million)

Table 37. North America Androgen Suppression Therapy Market Size by Country (2025-2030) & (US$ Million)

Table 38. Europe Androgen Suppression Therapy Market Size by Type (2019-2024) & (US$ Million)

Table 39. Europe Androgen Suppression Therapy Market Size by Type (2025-2030) & (US$ Million)

Table 40. Europe Androgen Suppression Therapy Market Size by Application (2019-2024) & (US$ Million)

Table 41. Europe Androgen Suppression Therapy Market Size by Application (2025-2030) & (US$ Million)

Table 42. Europe Androgen Suppression Therapy Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 43. Europe Androgen Suppression Therapy Market Size by Country (2019-2024) & (US$ Million)

Table 44. Europe Androgen Suppression Therapy Market Size by Country (2025-2030) & (US$ Million)

Table 45. China Androgen Suppression Therapy Market Size by Type (2019-2024) & (US$ Million)

Table 46. China Androgen Suppression Therapy Market Size by Type (2025-2030) & (US$ Million)

Table 47. China Androgen Suppression Therapy Market Size by Application (2019-2024) & (US$ Million)

Table 48. China Androgen Suppression Therapy Market Size by Application (2025-2030) & (US$ Million)

Table 49. Asia Androgen Suppression Therapy Market Size by Type (2019-2024) & (US$ Million)

Table 50. Asia Androgen Suppression Therapy Market Size by Type (2025-2030) & (US$ Million)

Table 51. Asia Androgen Suppression Therapy Market Size by Application (2019-2024) & (US$ Million)

Table 52. Asia Androgen Suppression Therapy Market Size by Application (2025-2030) & (US$ Million)

Table 53. Asia Androgen Suppression Therapy Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 54. Asia Androgen Suppression Therapy Market Size by Region (2019-2024) & (US$ Million)

Table 55. Asia Androgen Suppression Therapy Market Size by Region (2025-2030) & (US$ Million)

Table 56. Middle East, Africa, and Latin America Androgen Suppression Therapy Market Size by Type (2019-2024) & (US$ Million)

Table 57. Middle East, Africa, and Latin America Androgen Suppression Therapy Market Size by Type (2025-2030) & (US$ Million)

Table 58. Middle East, Africa, and Latin America Androgen Suppression Therapy Market Size by Application (2019-2024) & (US$ Million)

Table 59. Middle East, Africa, and Latin America Androgen Suppression Therapy Market Size by Application (2025-2030) & (US$ Million)

Table 60. Middle East, Africa, and Latin America Androgen Suppression Therapy Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 61. Middle East, Africa, and Latin America Androgen Suppression Therapy Market Size by Country (2019-2024) & (US$ Million)

Table 62. Middle East, Africa, and Latin America Androgen Suppression Therapy Market Size by Country (2025-2030) & (US$ Million)

Table 63. Pfizer Company Details

Table 64. Pfizer Business Overview

Table 65. Pfizer Androgen Suppression Therapy Product

Table 66. Pfizer Revenue in Androgen Suppression Therapy Business (2019-2024) & (US$ Million)

Table 67. Pfizer Recent Developments

Table 68. Astellas Company Details

Table 69. Astellas Business Overview

Table 70. Astellas Androgen Suppression Therapy Product

Table 71. Astellas Revenue in Androgen Suppression Therapy Business (2019-2024) & (US$ Million)

Table 72. Astellas Recent Developments

Table 73. Johnson & Johnson Company Details

Table 74. Johnson & Johnson Business Overview

Table 75. Johnson & Johnson Androgen Suppression Therapy Product

Table 76. Johnson & Johnson Revenue in Androgen Suppression Therapy Business (2019-2024) & (US$ Million)

Table 77. Johnson & Johnson Recent Developments

Table 78. AstraZeneca Company Details

Table 79. AstraZeneca Business Overview

Table 80. AstraZeneca Androgen Suppression Therapy Product

Table 81. AstraZeneca Revenue in Androgen Suppression Therapy Business (2019-2024) & (US$ Million)

Table 82. AstraZeneca Recent Developments

Table 83. Bayer Company Details

Table 84. Bayer Business Overview

Table 85. Bayer Androgen Suppression Therapy Product

Table 86. Bayer Revenue in Androgen Suppression Therapy Business (2019-2024) & (US$ Million)

Table 87. Bayer Recent Developments

Table 88. Merck Company Details

Table 89. Merck Business Overview

Table 90. Merck Androgen Suppression Therapy Product

Table 91. Merck Revenue in Androgen Suppression Therapy Business (2019-2024) & (US$ Million)

Table 92. Merck Recent Developments

Table 93. Tolmar Company Details

Table 94. Tolmar Business Overview

Table 95. Tolmar Androgen Suppression Therapy Product

Table 96. Tolmar Revenue in Androgen Suppression Therapy Business (2019-2024) & (US$ Million)

Table 97. Tolmar Recent Developments

Table 98. Zoladex Company Details

Table 99. Zoladex Business Overview

Table 100. Zoladex Androgen Suppression Therapy Product

Table 101. Zoladex Revenue in Androgen Suppression Therapy Business (2019-2024) & (US$ Million)

Table 102. Zoladex Recent Developments

Table 103. Ferring Pharmaceuticals Company Details

Table 104. Ferring Pharmaceuticals Business Overview

Table 105. Ferring Pharmaceuticals Androgen Suppression Therapy Product

Table 106. Ferring Pharmaceuticals Revenue in Androgen Suppression Therapy Business (2019-2024) & (US$ Million)

Table 107. Ferring Pharmaceuticals Recent Developments

Table 108. Jiangsu Hengrui Pharmaceuticals Company Details

Table 109. Jiangsu Hengrui Pharmaceuticals Business Overview

Table 110. Jiangsu Hengrui Pharmaceuticals Androgen Suppression Therapy Product

Table 111. Jiangsu Hengrui Pharmaceuticals Revenue in Androgen Suppression Therapy Business (2019-2024) & (US$ Million)

Table 112. Jiangsu Hengrui Pharmaceuticals Recent Developments

Table 113. CTTQ Company Details

Table 114. CTTQ Business Overview

Table 115. CTTQ Androgen Suppression Therapy Product

Table 116. CTTQ Revenue in Androgen Suppression Therapy Business (2019-2024) & (US$ Million)

Table 117. CTTQ Recent Developments

Table 118. Research Programs/Design for This Report

Table 119. Key Data Information from Secondary Sources

Table 120. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Androgen Suppression Therapy Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 2. Global Androgen Suppression Therapy Market Share by Type: 2023 VS 2030

Figure 3. Tablet Features

Figure 4. Injection Features

Figure 5. Global Androgen Suppression Therapy Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 6. Global Androgen Suppression Therapy Market Share by Application: 2023 VS 2030

Figure 7. Hospital Case Studies

Figure 8. Clinic Case Studies

Figure 9. Others Case Studies

Figure 10. Androgen Suppression Therapy Report Years Considered

Figure 11. Global Androgen Suppression Therapy Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 12. Global Androgen Suppression Therapy Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 13. Global Androgen Suppression Therapy Market Share by Region: 2023 VS 2030

Figure 14. Global Androgen Suppression Therapy Market Share by Players in 2023

Figure 15. Global Top Androgen Suppression Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Androgen Suppression Therapy as of 2023)

Figure 16. The Top 10 and 5 Players Market Share by Androgen Suppression Therapy Revenue in 2023

Figure 17. North America Androgen Suppression Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 18. North America Androgen Suppression Therapy Market Share by Type (2019-2030)

Figure 19. North America Androgen Suppression Therapy Market Share by Application (2019-2030)

Figure 20. North America Androgen Suppression Therapy Market Share by Country (2019-2030)

Figure 21. United States Androgen Suppression Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Canada Androgen Suppression Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Europe Androgen Suppression Therapy Market Size YoY (2019-2030) & (US$ Million)

Figure 24. Europe Androgen Suppression Therapy Market Share by Type (2019-2030)

Figure 25. Europe Androgen Suppression Therapy Market Share by Application (2019-2030)

Figure 26. Europe Androgen Suppression Therapy Market Share by Country (2019-2030)

Figure 27. Germany Androgen Suppression Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. France Androgen Suppression Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. U.K. Androgen Suppression Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Italy Androgen Suppression Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Russia Androgen Suppression Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Nordic Countries Androgen Suppression Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. China Androgen Suppression Therapy Market Size YoY (2019-2030) & (US$ Million)

Figure 34. China Androgen Suppression Therapy Market Share by Type (2019-2030)

Figure 35. China Androgen Suppression Therapy Market Share by Application (2019-2030)

Figure 36. Asia Androgen Suppression Therapy Market Size YoY (2019-2030) & (US$ Million)

Figure 37. Asia Androgen Suppression Therapy Market Share by Type (2019-2030)

Figure 38. Asia Androgen Suppression Therapy Market Share by Application (2019-2030)

Figure 39. Asia Androgen Suppression Therapy Market Share by Region (2019-2030)

Figure 40. Japan Androgen Suppression Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. South Korea Androgen Suppression Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. China Taiwan Androgen Suppression Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Southeast Asia Androgen Suppression Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. India Androgen Suppression Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Australia Androgen Suppression Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Middle East, Africa, and Latin America Androgen Suppression Therapy Market Size YoY (2019-2030) & (US$ Million)

Figure 47. Middle East, Africa, and Latin America Androgen Suppression Therapy Market Share by Type (2019-2030)

Figure 48. Middle East, Africa, and Latin America Androgen Suppression Therapy Market Share by Application (2019-2030)

Figure 49. Middle East, Africa, and Latin America Androgen Suppression Therapy Market Share by Country (2019-2030)

Figure 50. Brazil Androgen Suppression Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 51. Mexico Androgen Suppression Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 52. Turkey Androgen Suppression Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 53. Saudi Arabia Androgen Suppression Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 54. Israel Androgen Suppression Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 55. GCC Countries Androgen Suppression Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 56. Pfizer Revenue Growth Rate in Androgen Suppression Therapy Business (2019-2024)

Figure 57. Astellas Revenue Growth Rate in Androgen Suppression Therapy Business (2019-2024)

Figure 58. Johnson & Johnson Revenue Growth Rate in Androgen Suppression Therapy Business (2019-2024)

Figure 59. AstraZeneca Revenue Growth Rate in Androgen Suppression Therapy Business (2019-2024)

Figure 60. Bayer Revenue Growth Rate in Androgen Suppression Therapy Business (2019-2024)

Figure 61. Merck Revenue Growth Rate in Androgen Suppression Therapy Business (2019-2024)

Figure 62. Tolmar Revenue Growth Rate in Androgen Suppression Therapy Business (2019-2024)

Figure 63. Zoladex Revenue Growth Rate in Androgen Suppression Therapy Business (2019-2024)

Figure 64. Ferring Pharmaceuticals Revenue Growth Rate in Androgen Suppression Therapy Business (2019-2024)

Figure 65. Jiangsu Hengrui Pharmaceuticals Revenue Growth Rate in Androgen Suppression Therapy Business (2019-2024)

Figure 66. CTTQ Revenue Growth Rate in Androgen Suppression Therapy Business (2019-2024)

Figure 67. Bottom-up and Top-down Approaches for This Report

Figure 68. Data Triangulation

Figure 69. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Cancer Hormone Therapy Drugs Market Insights Forecast to 2030

Global Testosterone Replacement Therapy Market Insights Forecast to 2030

Global Male Hypogonadism Therapy Market Insights Forecast to 2030

Prostate Cancer Hormone Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Antihormonal Cancer Therapies Market Insights Forecast to 2030

Testosterone Hormone Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Breast Cancer Hormone Therapy Market Insights Forecast to 2030

Testosterone Blocker Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Hypogonadism Drug Market Research Report 2025

Global Hypogonadism Treatment Market Research Report 2025

Global 5α Reductase Inhibitors Market Research Report 2025

Global Testosterone Replacement Injectables Market Research Report 2024

Global Drugs For Hormonal Replacement Market Insights Forecast to 2030

Global Erectile Dysfunction Treatment Market Insights Forecast to 2030

Global Hormone Replacement Therapy Market Insights Forecast to 2030

Global Antiandrogen Market Insights Forecast to 2030

Global Androgen Antibody Market Research Report 2024

Estrogen Replacement Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Endocrine Therapy Medication Market Research Report 2024

RELATED REPORTS

Global Geriatric Care Services Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-17Q6174

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Hospice Software Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-8Z4276

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Geriatric Care Devices Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-8Q8325

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Allied Health Care Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-29V19536

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions